Endo International | ENDP - Pendapatan Penjualan



Penjualan Perubahan Tanggal
AbbVie USD 16.99B 1.99B 2026-06
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eli Lilly USD 22.97B 3.17B 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
Merck USD 16.6B 310M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pacira USD 192.4M 15.4M 2026-06
Perrigo USD 1.02B 51M 2026-06
Pfizer USD 15.03B 530M 2026-06
Phibro Animal Health USD 373.91M 10.02M 2025-12
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Takeda JPY 1.22T 130B 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Zoetis USD 2.5B 200M 2026-06